Stock IGX INTELGENX TECHNOLOGIES CORP.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Other languages IntelGenx Technologies Corp. OTC Bulletin Board

Equities

IGX

US45822R1014

End-of-day quote OTC Bulletin Board
Other stock markets
- CAD - Intraday chart for IntelGenx Technologies Corp.
05-28 IntelGenx Brief: Says Obtained Court-Approval of a Sale and Investment Solicitation Process; Had Recently Initiated Restructuring Proceedings Under the CCAA to Implement a Review of its Strategic Alternatives MT
05-28 ATAI Life Sciences AG entered into an agreement of purchase and sale to acquire the Assets of IntelGenx Technologies Corp.. CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
IntelGenx Brief: Says Obtained Court-Approval of a Sale and Investment Solicitation Process; Had Recently Initiated Restructuring Proceedings Under the CCAA to Implement a Review of its Strategic Alternatives
IntelGenx Obtains Court-Approval of a Sale and Investment Solicitation Process
ATAI Life Sciences AG entered into an agreement of purchase and sale to acquire the Assets of IntelGenx Technologies Corp..
IntelGenx Begins Restructuring Proceedings Under CCAA to Implement Review of Strategic Alternatives
IntelGenx Initiates Restructuring Proceedings Under the CCAA to Implement a Review of its Strategic Alternatives
IntelGenx Brief: Initiating Restructuring Proceedings Under the CCAA to Implement a Review of its Strategic Alternatives
IntelGenx Initiates Restructuring Proceedings Under the CCAA to Implement a Review of its Strategic Alternatives
IntelGenx Technologies Corp. Announces Board Resignations
Canadian Investment Regulatory Organization Trading Halt - IGX
IntelGenx Technologies Initiates Restructuring Proceedings Under the CCAA to Implement a Review of its Strategic Alternatives
IntelGenx: Q1 Earnings Snapshot
IntelGenx Technologies Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024
IntelGenx Announces Voting Results on Election of Directors
IntelGenx Announces First Parkinson’s Disease Patients Dosed with Montelukast VersaFilm® in Phase 2 ‘MONTPARK’ Clinical Trial
Intelgenx Announces First Parkinson?S Disease Patients Dosed with Montelukast Versafilm® in Phase 2 ?Montpark? Clinical Trial
IntelGenx Updates Status of Buprenorphine Buccal Film ANDA
IntelGenx Updates Status of Buprenorphine Buccal Film ANDA
IntelGenx Updates Status of Buprenorphine Buccal Film ANDA
IntelGenx Corp. Updates Status of Buprenorphine Buccal Film ANDA
IntelGenx Technologies Narrows Q4 Loss, Revenue Rises
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IGXT Stock
  4. IGX Stock
  5. News IntelGenx Technologies Corp.
  6. Other languages